154 related articles for article (PubMed ID: 10996920)
1. [HIV-1 associated encephalopathy and myelopathy].
Eggers C
Nervenarzt; 2000 Aug; 71(8):677-84. PubMed ID: 10996920
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 associated encephalopathy and myelopathy.
Eggers Ch;
J Neurol; 2002 Aug; 249(8):1132-6. PubMed ID: 12420723
[TBL] [Abstract][Full Text] [Related]
3. HIV-associated neurocognitive disorder and HIV-associated myelopathy in a patient with a preserved CD4, but high viral load-a rarely reported phenomenon: a case report and literature review.
Ayele BA; Amogne W; Gemechu L
BMC Infect Dis; 2020 Aug; 20(1):574. PubMed ID: 32758161
[TBL] [Abstract][Full Text] [Related]
4. Subtle neuropsychological impairment and minor cognitive-motor disorder in HIV-1 infection. Neuroradiological, neurophysiological, neuroimmunological, and virological correlates.
Goodkin K; Wilkie FL; Concha M; Asthana D; Shapshak P; Douyon R; Fujimura RK; LoPiccolo C
Neuroimaging Clin N Am; 1997 Aug; 7(3):561-79. PubMed ID: 9376968
[TBL] [Abstract][Full Text] [Related]
5. Neurodevelopmental/neuroradiologic recovery of a child infected with HIV after treatment with combination antiretroviral therapy using the HIV-specific protease inhibitor ritonavir.
Tepper VJ; Farley JJ; Rothman MI; Houck DL; Davis KF; Collins-Jones TL; Wachtel RC
Pediatrics; 1998 Mar; 101(3):E7. PubMed ID: 9493492
[TBL] [Abstract][Full Text] [Related]
6. [Neurologic complications of HIV infection in the HAART era. Rapid and efficient diagnosis].
Arendt G; Haslinger BA
MMW Fortschr Med; 2003 Apr; 145 Spec No 1():66-9. PubMed ID: 15011596
[TBL] [Abstract][Full Text] [Related]
7. Delayed central nervous system virus suppression during highly active antiretroviral therapy is associated with HIV encephalopathy, but not with viral drug resistance or poor central nervous system drug penetration.
Eggers C; Hertogs K; Stürenburg HJ; van Lunzen J; Stellbrink HJ
AIDS; 2003 Sep; 17(13):1897-906. PubMed ID: 12960822
[TBL] [Abstract][Full Text] [Related]
8. Age-dependent neurologic manifestations of HIV infection in childhood.
Angelini L; Zibordi F; Triulzi F; Cinque P; Giudici B; Pinzani R; Plebani A
Neurol Sci; 2000 Jun; 21(3):135-42. PubMed ID: 11076001
[TBL] [Abstract][Full Text] [Related]
9. HIV in the brain: an interview with Dr. Michael Wool, UCLA researcher.
Wool M
Posit Dir News; 1998 Jan; 10(1):18-24. PubMed ID: 11365052
[TBL] [Abstract][Full Text] [Related]
10. When do models of NeuroAIDS faithfully imitate "the real thing"?
Gelman BB; Endsley J; Kolson D
J Neurovirol; 2018 Apr; 24(2):146-155. PubMed ID: 29256039
[TBL] [Abstract][Full Text] [Related]
11. Novel delivery system enhances efficacy of antiretroviral therapy in animal model for HIV-1 encephalitis.
Spitzenberger TJ; Heilman D; Diekmann C; Batrakova EV; Kabanov AV; Gendelman HE; Elmquist WF; Persidsky Y
J Cereb Blood Flow Metab; 2007 May; 27(5):1033-42. PubMed ID: 17063148
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal viral replication and cerebral deficits in different stages of human immunodeficiency virus disease.
Arendt G; Nolting T; Frisch C; Husstedt IW; Gregor N; Koutsilieri E; Maschke M; Angerer A; Obermann M; Neuen-Jacob E; Adams O; Loeffert S; Riederer P; ter Meulen V; Sopper S;
J Neurovirol; 2007 Jun; 13(3):225-32. PubMed ID: 17613712
[TBL] [Abstract][Full Text] [Related]
13. Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors.
Sacktor NC; Skolasky RL; Lyles RH; Esposito D; Selnes OA; McArthur JC
J Neurovirol; 2000 Feb; 6(1):84-8. PubMed ID: 10787000
[TBL] [Abstract][Full Text] [Related]
14. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
[TBL] [Abstract][Full Text] [Related]
15. HIV, dementia and antiretroviral drugs: 30 years of an epidemic.
Manji H; Jäger HR; Winston A
J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1126-37. PubMed ID: 23378642
[TBL] [Abstract][Full Text] [Related]
16. [Mechanisms of cerebral damage in patients with HIV-infection].
Beliakov NA; Medvedev SV; Trofimova TN; Rassokhin VV; Dement'eva NE; Shelomov SA
Vestn Ross Akad Med Nauk; 2012; (9):4-12. PubMed ID: 23210166
[TBL] [Abstract][Full Text] [Related]
17. HIV-associated dementia: new insights into disease pathogenesis and therapeutic interventions.
Swindells S; Zheng J; Gendelman HE
AIDS Patient Care STDS; 1999 Mar; 13(3):153-63. PubMed ID: 10375263
[TBL] [Abstract][Full Text] [Related]
18. Dementia and neurocognitive disorders due to HIV-1 infection.
Ances BM; Ellis RJ
Semin Neurol; 2007 Feb; 27(1):86-92. PubMed ID: 17226745
[TBL] [Abstract][Full Text] [Related]
19. [Dementia and human inmmunodeficiency virus infection].
Gray F
Rev Neurol (Paris); 1998; 154 Suppl 2():S91-8. PubMed ID: 9834549
[TBL] [Abstract][Full Text] [Related]
20. [Neurological manifestations of HIV-infection (review)].
Boĭko AN; Mazus AI; Tsyganova EV; Ovcharov VV; Boĭko OV; Serkov SV; Gusev EI
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9 Pt 2):23-28. PubMed ID: 23378988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
